Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease

Abstract

Background Nonalcoholic fatty liver disease (NAFLD) is now the major contributor to chronic liver disease. Disorders of lipid metabolism are a major element in the emergence of NAFLD. This research intended to explore lipid metabolism-related clusters in NAFLD and establish a prediction biomarker. Methods The expression mode of lipid metabolism-related genes (LMRGs) and immune characteristics in NAFLD were examined. The “ConsensusClusterPlus” package was utilized to investigate the lipid metabolism-related subgroup. The WGCNA was utilized to determine hub genes and perform functional enrichment analysis. After that, a model was constructed by machine learning techniques. To validate the predictive effectiveness, receiver operating characteristic curves, nomograms, decision curve analysis (DCA), and test sets were used. Lastly, gene set variation analysis (GSVA) was utilized to investigate the biological role of biomarkers in NAFLD. Results Dysregulated LMRGs and immunological responses were identified between NAFLD and normal samples. Two LMRG-related clusters were identified in NAFLD. Immune infiltration analysis revealed that C2 had much more immune infiltration. GSVA also showed that these two subtypes have distinctly different biological features. Thirty cluster-specific genes were identified by two WGCNAs. Functional enrichment analysis indicated that cluster-specific genes are primarily engaged in adipogenesis, signalling by interleukins, and the JAK-STAT signalling pathway. Comparing several models, the random forest model exhibited good discrimination performance. Importantly, the final five-gene random forest model showed excellent predictive power in two test sets. In addition, the nomogram and DCA confirmed the precision of the model for NAFLD prediction. GSVA revealed that model genes were down-regulated in several immune and inflammatory-related routes. This suggests that these genes may inhibit the progression of NAFLD by inhibiting these pathways. Conclusions This research thoroughly emphasized the complex relationship between LMRGs and NAFLD and established a five-gene biomarker to evaluate the risk of the lipid metabolism phenotype and the pathologic results of NAFLD.

Certolizumab Has Favorable Efficacy on Preventing Pancreas and Target Organs Damage in Acute Pancreatitis

“…Epithelial to mesenchymal transition is a key process of pancreatic stellate cell transition in pancreatitis 31 . Disorders of lipid metabolism are closely associated with the development and severity of AP 32 . Moreover, apoptosis of pancreatic cells is tightly associated with AP severity 13 .…”

Identification of novel biomarkers based on lipid metabolism-related molecular subtypes for moderately severe and severe acute pancreatitis

“…After excluding the MAP samples, 30 NMAP patients (20 MSAP and 10 SAP) and 32 normal individuals were included in this research. Considering the number of genes and their relevance score, as well as previous studies, we selected 1004 LMRGs (relevance score > 10) from the GeneCards database for this analysis [ 13 , 14 ]. With adjusted P < 0.05 and |logFC|> 2 as the criterion, differentially expressed genes (DEGs) between normal and NMAP samples were found by the “limma” program [ 15 ].…”

Identification of the methotrexate resistance-related diagnostic markers in osteosarcoma via adaptive total variation netNMF and multi-omics datasets

“…A single sample gene set enrichment analysis (ssGSEA) ( Liu et al, 2023b ) method was used to analyze the differences in 28 immune cell infiltrates between the high-risk and low-risk groups. Tumor microenvironment analysis was performed on the gene expression data of osteosarcoma using an R package estimate ( Zhang et al, 2023b ) to obtain the immune score, stromal score, and estimate score for each patient, and the difference in scores between the high-risk and low-risk groups was analyzed.…”